Takeda Pharmaceutical (NYSE:TAK) recently announced the acquisition of Irish drug maker Shire in a reported $56-billion deal expected to close later this year.
Shire, a global biotech firm with a focus on curing rare diseases, maintains branch offices on Baxter Way in Westlake Village and on Lawrence Drive and Rancho Conejo Boulevard in Newbury Park.
Takeda’s research and development efforts also involve plasma driven therapies and vaccines for oncology, gastroenterology and neuroscience. The co...
Oops! An active online subscription is required to access this content.
Please login below or Subscribe today!